Does FARICIMAB Cause Neovascular age-related macular degeneration? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Neovascular age-related macular degeneration have been filed in association with FARICIMAB (VABYSMO). This represents 3.7% of all adverse event reports for FARICIMAB.
14
Reports of Neovascular age-related macular degeneration with FARICIMAB
3.7%
of all FARICIMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Neovascular age-related macular degeneration From FARICIMAB?
Of the 14 reports, 1 (7.1%) required hospitalization.
Is Neovascular age-related macular degeneration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FARICIMAB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does FARICIMAB Cause?
Off label use (32)
Uveitis (31)
No adverse event (27)
Drug ineffective (22)
Eye inflammation (18)
Cataract (16)
Death (16)
Vitritis (16)
Retinal haemorrhage (15)
Blindness (14)
What Other Drugs Cause Neovascular age-related macular degeneration?
AFLIBERCEPT (228)
RANIBIZUMAB (182)
PENTOSAN POLYSULFATE (139)
BEVACIZUMAB (88)
ADALIMUMAB (55)
BROLUCIZUMAB-DBLL (53)
PEGCETACOPLAN (40)
APIXABAN (36)
FARICIMAB-SVOA (32)
ATORVASTATIN (15)
Which FARICIMAB Alternatives Have Lower Neovascular age-related macular degeneration Risk?
FARICIMAB vs FARICIMAB-SVOA
FARICIMAB vs FARICIMAB\FARICIMAB-SVOA
FARICIMAB vs FASLODEX
FARICIMAB vs FAVIPIRAVIR
FARICIMAB vs FEBUXOSTAT